What are the lifetime odds of developing end-stage kidney disease requiring dialysis or transplant?
Evidence quality 4.88/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
Lifetime probability · lifetime, US adult
1 in 29
3.5% lifetime chance
Most people underestimate this.
range 1 in 40 to 1 in 20
● your factors — click this risk ▾ to reveal
≈ As likely as
Perceived
Kidney failure rarely ranks highly in surveys of health fears, despite being among the most burdensome chronic conditions in US medicine. Most people associate dialysis with a distant, elderly relative rather than themselves. Awareness is generally low among those without diabetes or hypertension -- the two conditions that account for nearly 70% of ESRD cases.
Rough estimate: Most people without chronic disease would guess under 1% lifetime -- substantially below the actual 3-4%
Source: editorial intuition, not polled
Actual
~130,000 new ESRD cases per year in the US
US adults
Show derivation
Grams et al. (2013, J Am Soc Nephrol) calculated lifetime risk of ESRD from birth using 2013 USRDS data. Overall lifetime risk was approximately 3.5% for men and 3.0% for women, averaging roughly 3.3% across sexes. Using 3.5% as a round central estimate consistent with the published range (2.0%--8.0% by race/sex subgroup) gives lifetime_us_adult = 0.035. This is a prevalence-based lifetime risk, not derived from simple annual-rate compounding, and directly reflects the Grams 2013 published result rather than a naive calculation from the current annual incidence.
Caveats: The 3.5% figure is a lifetime cohort risk calculated from the 2013 USRDS registr…
The 3.5% figure is a lifetime cohort risk calculated from the 2013 USRDS registry. ESRD rates have changed over time: the incidence rate peaked around 2001 and has modestly declined through improved diabetes and hypertension management, though the absolute number of people on dialysis continues to rise with an aging population. The racial disparity is large and well-documented: a Black American faces roughly 2.5 times the lifetime ESRD risk of a white American, driven by higher rates of hypertension and diabetes, differential access to primary care, and possible genetic factors (APOL1 gene variants). This entry does not cover acute kidney injury (AKI) from which most patients recover; it specifically covers kidney failure requiring dialysis or transplant for survival.
Risks at similar odds
Other risks with roughly the same likelihood — useful for calibration.
Recently viewed on this device
Stored locally — clear anytime.
Pick challenger
End-stage renal disease — kidney failure requiring dialysis or transplant for survival — affects more Americans than most people realize. The USRDS records roughly 130,000 new cases per year in the United States; about 808,000 Americans are currently living with ESRD. Published lifetime risk analysis by Grams et al. (2013, J Am Soc Nephrol) using USRDS cohort data puts the lifetime probability at approximately 3.5% for men and 3.0% for women — averaging around 1 in 29 for a typical US adult. That is substantially higher than the lifetime risk of dying from a car crash.
The risk is not evenly distributed. Diabetes accounts for roughly 40% of new ESRD cases and hypertension for another 28%; someone with both conditions faces a lifetime risk an order of magnitude above the population average. Racial disparities are among the largest in US medicine: non-Hispanic Black men face a lifetime ESRD risk of 8.0%, versus 3.1% for non-Hispanic white men — a 2.5-fold difference driven by higher hypertension prevalence, differential access to early nephrology care, and genetic risk factors including the APOL1 gene variant. The lifetime risk for non-Hispanic Black women (6.8%) is also far above the white female average (2.0%).
Once established, ESRD requires permanent treatment: approximately 70% of patients receive chronic dialysis (typically three sessions per week, four or more hours each) and 30% have a functioning kidney transplant. The dialysis burden is substantial — it imposes constraints on travel, diet, and employment that persist for the rest of the patient’s life unless a transplant becomes available. The kidneys are the only major organ for which there is no partial medical substitute once function is irreversibly lost; ESRD is therefore not merely a health risk but a fundamental alteration of daily life.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] Journal of the American Society of Nephrology (Grams et al., 2013) — Lifetime Risk of ESRD: A Meaningful Concept?
Lifetime Risk of ESRD: A Meaningful Concept?- Statistic
Lifetime risk of ESRD from birth: 3.1% non-Hispanic white men, 8.0% non-Hispanic Black men, 2.0% non-Hispanic white women, 6.8% non-Hispanic Black women (2013 USRDS data)- Excerpt
“"Using 2013 USRDS data, the lifetime risk of ESRD was 3.1% for non-Hispanic white men, 8.0% for non-Hispanic Black men, 2.0% for non-Hispanic white women, and 6.8% for non-Hispanic Black women. The lifetime risk of ESRD from birth increased from 3.5% in 2000 to 4.0% in 2013 in males and decreased from 3.0% to 2.8% in females." ”
- Source data from
- 2013-08-01
- Accessed
- 2026-05-14 · archived copy
- Calculation
- Published lifetime risk figures are used directly without recalculation. The population-weighted average across sex and race groups approximates 3.3--3.5%. Using 3.5% as the central estimate for lifetime_us_adult = 0.035. The racial disparity is substantial: non-Hispanic Black men face ~2.5x the ESRD risk of non-Hispanic white men (8.0% vs 3.1%), which is reflected in personal_factor_multipliers.
- Independence
- Grams et al. (2013) used the USRDS (United States Renal Data System) registry, which is the authoritative national database for ESRD incidence and prevalence, maintained by NIDDK. This analysis is independent of insurance claims data and represents the most frequently cited academic source for US lifetime ESRD risk.
-
[2] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — Kidney Disease Statistics for the United States
Kidney Disease Statistics for the United States- Statistic
~808,000 Americans living with ESRD; ~130,000 new ESRD cases per year; ~70% on dialysis, ~30% with functioning kidney transplant- Excerpt
“"In 2019, more than 808,000 Americans were living with ESRD. More than 131,000 people began treatment for kidney failure in 2019. About 70 percent of ESRD patients receive dialysis and about 30 percent have a functioning kidney transplant." ”
- Source data from
- 2022-01-01
- Accessed
- 2026-05-14 · archived copy
- Calculation
- 130,000 new cases per year / 260 million US adults = 0.0005 per adult per year. Over 59 years: 1 − (1 − 0.0005)^59 ≈ 0.028. This independent calculation from the annual incidence rate yields ~2.8%, broadly consistent with the Grams 2013 lifetime risk estimate of 3.5% (which uses a cohort method and is slightly higher because it captures risk from birth through the full lifespan). The Grams figure is used as the primary estimate because it was specifically designed to measure lifetime risk.
- Independence
- NIDDK maintains the USRDS and provides national-level statistics independently of the Grams 2013 academic analysis. The two sources draw on the same underlying USRDS registry data but are independently published by a government agency and an academic research team respectively.